News Summary
Matregenix Inc., a nanofiber technology company in Mission Viejo, has received a $2.039 million Phase II grant from the NIDCR to further develop MatriNova™, a nanofiber membrane designed for enhanced bone regeneration. This collaborative project with the University of Michigan School of Dentistry aims to improve guided bone regeneration techniques, reflecting the company’s growing credibility in the healthcare R&D sector. The funding will enable significant advancements in refining MatriNova™, supporting improved patient outcomes in dental and craniofacial procedures.
Mission Viejo, California – Matregenix Inc., a nanofiber technology company based in Mission Viejo, has been awarded a $2.039 million Phase II grant from the National Institute of Dental and Craniofacial Research (NIDCR) to advance the development of MatriNova™, an innovative nanofiber membrane aimed at enhancing bone regeneration. This grant is part of a competitive funding initiative through the National Institutes of Health (NIH).
The grant will specifically support the advancement of MatriNova™, which is designed for use in guided bone regeneration (GBR) procedures. The project is a collaborative effort with the University of Michigan School of Dentistry, directed by Professor Marco Bottino. This partnership builds on an existing relationship established in 2021, illustrating a commitment to harnessing academic expertise in the field of dental and craniofacial surgery.
Matregenix has achieved significant success in securing funding through Small Business Innovation Research (SBIR) awards, reflecting the company’s innovative potential and credibility within the healthcare research and development (R&D) sector. To date, the company has received a total of nine SBIR and Small Business Technology Transfer (STTR) grants from various U.S. federal agencies including the NIH and the Department of Defense.
The NIH Phase II grant will facilitate major advancements in refining and validating the MatriNova GBR membrane, which is designed to enhance bone healing options for patients undergoing dental and craniofacial procedures. As guided bone regeneration plays a crucial role in these medical interventions, the development of more effective materials promises to improve patient outcomes dramatically.
In addition to securing funding, Matregenix has scaled its operations by moving into a state-of-the-art manufacturing facility. This new 18,000 sq. ft. facility, located in Mission Viejo, enhances the company’s capacity for scalable nanofiber production. The upgraded manufacturing capabilities are expected to meet the growing demand for advanced biomaterials and expedite the transition from laboratory innovations to market applications.
Significance of the Grant
The recent grant marks a significant milestone for Matregenix, as it not only supports the development of an innovative product but also validates the company’s technology platform. The funding is instrumental in addressing unmet needs in the biomedical sphere, particularly in improving techniques associated with bone regeneration.
Expanding Opportunities
Matregenix specializes in the design, development, and manufacturing of highly tunable nanofibrous materials tailored for various applications. Their focus spans not only the biomedical sector but also filtration solutions, thus providing comprehensive development and manufacturing services aimed at a broader range of market needs.
Future Prospects
Looking ahead, the innovation presented by MatriNova™ could lead to significant advancements in dental and craniofacial care, potentially transforming how medical professionals approach bone regeneration. With the backing of NIH funding and strategic collaboration with academic institutions, Matregenix is well-positioned to influence the future of biomaterials in healthcare.
The combined efforts of Matregenix and the University of Michigan are set to pave the way for groundbreaking developments that could impact countless patients requiring effective solutions for bone healing. As the company continues to expand its technological and manufacturing capabilities, the future of Matregenix appears promising.
Deeper Dive: News & Info About This Topic
HERE Resources
Additional Resources
- Matregenix Awarded $2M NIH Grant
- Wikipedia: Nanofiber
- The Vesta Group Secures $16M Funding
- Google Search: Guided Bone Regeneration
- Matregenix Receives SBIR Phase II Award
- Encyclopedia Britannica: Biomaterials
Author: STAFF HERE MISSION VIEJO WRITER
MISSION VIEJO STAFF WRITER The MISSION VIEJO STAFF WRITER represents the experienced team at HEREMissionViejo.com, your go-to source for actionable local news and information in Mission Viejo, Orange County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Oso Fit 5K Fun Run and Community Health Fair, Walk Against Drugs & Community Fair, and National Night Out. Our coverage extends to key organizations like the Mission Viejo Chamber of Commerce and Providence Mission Hospital Mission Viejo, plus leading businesses in retail and education that power the local economy such as The Shops at Mission Viejo, Capistrano Unified School District, and Amazon Delivery Station. As part of the broader HERE network, including HEREAnaheim.com, HEREBeverlyHills.com, HERECostaMesa.com, HERECoronado.com, HEREHollywood.com, HEREHuntingtonBeach.com, HERELongBeach.com, HERELosAngeles.com, HERESanDiego.com, and HERESantaAna.com, we provide comprehensive, credible insights into California's dynamic landscape.
